OBJECTIVE -To examine the association between white blood cell (WBC) count and metabolic syndrome (MetS) by growth periods in black versus white individuals in the general population.
pidemiological and clinical studies have shown that white blood cell (WBC) count, an important cellular marker of systemic inflammation, is associated with coronary heart disease, type 2 diabetes, and multiple components of metabolic syndrome (MetS), including obesity, insulin resistance, hypertension, and dyslipidemia (1) (2) (3) (4) . The objective of the present study is to examine the association between WBC count and MetS by age-group, cross-sectionally and longitudinally, in black versus white asymptomatic individuals enrolled in the Bogalusa Heart Study.
RESEARCH DESIGN AND METHODS -Two cross-sectional surveys of children aged 4 -17 years in 1988 -1993 and two surveys of young adults aged 18 -38 years in 1988 -1996 were conducted for cardiovascular risk factors, including WBC count. Individuals who had a WBC count outside the clinically normal range (below 2,000 cells/l or above 12,000 cells/l) were excluded from analyses to remove influence of acute bacterial infection and other medical disorders. Subjects who were taking medications for hypertension, diabetes, and/or dyslipidemia or had missing values for any of the MetS risk variables were also excluded. The final sample size for the current cross-sectional analysis was 1,137 preadolescents (aged 4 -11 years), 1,542 adolescents (aged 12-17 years), and 1,503 adults (aged 18 -38 years). In this cohort, a subset of 743 adults was followed for 8.1-20.8 years with a mean follow-up period of 12.7 years.
Statistical methods BMI (in children), waist circumference (in adults), HDL cholesterol, fasting triglycerides, and fasting glucose were selected as MetS components. In cross-sectional analysis of preadolescents, adolescents, and adults, the sex-and age-specific top quartiles (bottom quartile for HDL cholesterol) were used to define the adverse levels of the MetS components by race group because widely accepted cutoff values are not available for preadolescents and adolescents. In the longitudinal adult cohort, the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATPIII) cutoffs were used to define the adverse levels. Pearson correlation was used to assess the association of WBC count with the MetS components, adjusting for age, sex, and smoking (for adults). The difference in the correlation coefficients between race groups was tested by Fisher z test.
RESULTS -White versus black subjects had a significantly higher WBC count among preadolescents (6,472 vs. 5,927 cells/l, P Ͻ 0.001), adolescents (6,270 vs. 5,697 cells/l, P Ͻ 0.001), and adults (6,496 vs. 6,037 cells/l, P Ͻ 0.001). The racial differences in prevalence of MetS were significant in preadolescents (whites versus blacks: 18.5 vs. 12.9%, P Ͻ 0.05) and in adults (14.5 vs. 19.2%, P Ͻ 0.05), but not in adolescents (15.2 vs. 14.3%, P Ͼ 0.05). Mean values of WBC increased significantly with the increasing number of MetS components with adverse levels in adolescents (P Ͻ 0.001 in whites, P ϭ 0.040 in blacks) and adults (P Ͻ 0.001 in whites, P ϭ 0.015 in
blacks). Table 1 shows Pearson correlation coefficients of WBC count with MetS risk variables by race and age-groups, adjusting for age sex and smoking (for adults), in cross-sectional and longitudinal analyses. In general, WBC was associated with more MetS variables in whites than in blacks, especially among adults, in both cross-sectional and longitudinal analyses. Furthermore, in the longitudinal analyses, the mean values of baseline WBC count increased significantly with the increasing number of MetS components with adverse levels at follow-up in whites (P Ͻ 0.001), but not in blacks (P ϭ 0.137).
CONCLUSIONS -The present study demonstrated a pronounced black-white difference in the relationship between WBC count and MetS risk variables in children and young adults in both crosssectional and longitudinal analyses. The Coronary Artery Risk Development in Young Adults (CARDIA) study investigated correlates of leukocyte count in 4,981 black and white young adults aged 18 -30 years similar to the age range of the present study cohort; however, the data were not analyzed separately by race group (5). In the Atherosclerosis Risk in Communities (ARIC) study, the associations of WBC count with sociodemographic and cardiovascular risk factors were examined in 4,832 white and 1,830 black nonsmokers aged 45-64 years; this cross-sectional analysis did not show black-white difference in the associations for most of the risk factors (6) . Therefore, the findings of the blackwhite contrasts in the present study need confirmation, particularly in populations of similar ages.
In the present study, WBC count was significantly lower in blacks than in whites; this racial difference persisted from childhood into adulthood. This observation is consistent with reports from other studies (5-7). However, levels of Creactive protein, another biomarker of inflammation, were found to be significantly higher in blacks than in whites in our previous report in a cohort from the same community (8) . Although blacks have higher prevalence rates of type 2 diabetes and cardiovascular disease (9), studies, including ours, in both children and adults showed lower prevalence of MetS in blacks (10 -12) . It is proposed that the ethnic differences in triglycerides and HDL cholesterol levels lead to underdiagnosis of MetS in blacks (12) . In the cross-sectional analysis of the present study, the prevalence of MetS was found to be lower in black preadolescents but higher in black adults than their white counterparts. Taken together, the pathophysiological mechanisms underlying the association between WBC count and MetS in racial groups may be divergent and need to be elucidated.
